Frontier Capital Management Co. LLC Buys New Stake in HealthEquity, Inc. (NASDAQ:HQY)

Frontier Capital Management Co. LLC purchased a new position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 43,760 shares of the company's stock, valued at approximately $4,199,000. Frontier Capital Management Co. LLC owned 0.05% of HealthEquity as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Ameritas Investment Partners Inc. boosted its holdings in HealthEquity by 0.3% in the fourth quarter. Ameritas Investment Partners Inc. now owns 33,856 shares of the company's stock worth $3,248,000 after acquiring an additional 88 shares in the last quarter. Smartleaf Asset Management LLC raised its position in shares of HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after purchasing an additional 98 shares during the last quarter. Louisiana State Employees Retirement System boosted its stake in HealthEquity by 0.4% in the 4th quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company's stock worth $2,322,000 after purchasing an additional 100 shares in the last quarter. Oregon Public Employees Retirement Fund grew its position in HealthEquity by 0.6% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company's stock valued at $1,706,000 after purchasing an additional 100 shares during the last quarter. Finally, State of Michigan Retirement System lifted its position in HealthEquity by 0.5% in the 4th quarter. State of Michigan Retirement System now owns 20,722 shares of the company's stock valued at $1,988,000 after acquiring an additional 100 shares in the last quarter. Institutional investors own 99.55% of the company's stock.

Insider Transactions at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction dated Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total transaction of $446,487.50. Following the completion of the sale, the director now owns 84,969 shares in the company, valued at approximately $6,597,842.85. This trade represents a 6.34% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Michael Henry Fiore sold 8,881 shares of HealthEquity stock in a transaction that occurred on Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the sale, the executive vice president now owns 56,655 shares in the company, valued at approximately $4,433,820.30. The trade was a 13.55% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company's stock.

Wall Street Analyst Weigh In

HQY has been the topic of a number of research analyst reports. Barrington Research reaffirmed an "outperform" rating and set a $112.00 price target on shares of HealthEquity in a report on Friday, April 11th. KeyCorp reduced their price target on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a research note on Wednesday, April 16th. Wells Fargo & Company increased their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research report on Wednesday, February 26th. Raymond James upgraded shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and decreased their target price for the company from $120.00 to $115.00 in a research note on Tuesday, March 25th. Finally, The Goldman Sachs Group reduced their price objective on HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research report on Thursday, March 27th. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average price target of $111.75.

HealthEquity Stock Performance

NASDAQ HQY traded up $0.33 on Tuesday, reaching $96.99. 1,537,007 shares of the stock were exchanged, compared to its average volume of 791,498. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $115.59. The firm has a market capitalization of $8.39 billion, a PE ratio of 88.98, a PEG ratio of 1.60 and a beta of 0.45. The company's 50-day simple moving average is $87.82 and its two-hundred day simple moving average is $96.81.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.